• Seeking Alpha

Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Seeking Alpha / 2 hours from now 1 Views

–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers –

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Next post
Marriott International Declares Quarterly Cash Dividend

Comments

Just Posted

  • Silver Added to USGS 2025 List of Critical Minerals

    4 hours from now

  • Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs

    4 hours from now

  • Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting

    4 hours from now

  • Tomingley Drilling har upptäckt en ny mineralisering i McLeans

    4 hours from now

  • Swvl Received Nasdaq Notification Regarding Minimum Market Value Deficiency

    4 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1980

Categories

  • Seeking Alpha 1980

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts